Form 8-K - Current report:
SEC Accession No. 0000950170-22-005777
Filing Date
2022-04-19
Accepted
2022-04-19 07:02:00
Documents
13
Period of Report
2022-04-19
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K acet-20220419.htm   iXBRL 8-K 49345
2 EX-99.1 acet-ex99_1.htm EX-99.1 15168
  Complete submission text file 0000950170-22-005777.txt   188656

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20220419.xsd EX-101.SCH 2498
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20220419_pre.xml EX-101.PRE 10332
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20220419_lab.xml EX-101.LAB 13996
7 EXTRACTED XBRL INSTANCE DOCUMENT acet-20220419_htm.xml XML 4877
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 22833448
SIC: 2834 Pharmaceutical Preparations